PureTech Health plc (OTCMKTS:PTCHF) Sees Significant Increase in Short Interest

PureTech Health plc (OTCMKTS:PTCHF) was the target of a significant increase in short interest during the month of February. As of February 28th, there was short interest totalling 91,700 shares, an increase of 93.5% from the February 13th total of 47,400 shares. Based on an average trading volume of 1,500 shares, the short-interest ratio is presently 61.1 days.

PureTech Health Price Performance

PTCHF opened at $1.77 on Friday. PureTech Health has a 52 week low of $1.66 and a 52 week high of $3.00. The business’s fifty day simple moving average is $1.75 and its 200 day simple moving average is $1.92.

About PureTech Health

PureTech Health plc, engages in the development and commercialization of biotechnology and pharmaceutical solutions in the United States. The company is developing LYT-100, which is under Phase 2 stage, to treat idiopathic pulmonary fibrosis (IPF); and LYT-200, a IgG4 monoclonal antibody, currently under Phase 1/2 stage, targeting galectin-9 for treating solid tumors and hematological malignancies.